|
covid-19 |
25 |
|
sars-cov-2 |
21 |
|
coronavirus |
20 |
|
immune activation |
14 |
|
intestine |
14 |
|
replication |
14 |
|
sars-cov |
14 |
|
viral replication |
13 |
|
mouse |
11 |
|
murine |
11 |
|
n501y |
11 |
|
rat |
11 |
|
sars-cov-2 variants |
11 |
|
susceptibility |
11 |
|
influenza a virus |
10 |
|
animal |
9 |
|
antibody-dependent cell-mediated cytotoxicity |
9 |
|
circrna |
9 |
|
ex vivo |
9 |
|
flavivirus |
9 |
|
genome mutation |
9 |
|
h1n1 influenza virus |
9 |
|
hemagglutinin |
9 |
|
human respiratory syncytial virus |
9 |
|
interferon |
9 |
|
lethal mouse model |
9 |
|
lung damage |
9 |
|
lung pathology |
9 |
|
mice |
9 |
|
mrna |
9 |
|
temperature |
9 |
|
dendritic cells |
8 |
|
macrophages |
8 |
|
endonuclease activity |
7 |
|
h7n7 virus |
7 |
|
hcov-229e |
7 |
|
ire1 |
7 |
|
lipidomics |
7 |
|
mdms |
7 |
|
mers-cov |
7 |
|
modcs |
7 |
|
ms |
7 |
|
mutation |
7 |
|
neurogenesis |
7 |
|
pa protein |
7 |
|
pan-a37s |
7 |
|
pan-a37s/i61t |
7 |
|
pan-a37s/v63i |
7 |
|
pathogenicity |
7 |
|
polymerase activity |
7 |
|
spermatogenesis |
7 |
|
uhplc |
7 |
|
upr |
7 |
|
zika virus |
7 |
|
antiviral |
6 |
|
ar-12 |
6 |
|
hsp90β |
6 |
|
inhibitor |
6 |
|
kinase |
6 |
|
nucleoprotein |
6 |
|
zika |
6 |
|
acly |
5 |
|
competing endogenous rna |
5 |
|
delta |
5 |
|
metabolomics |
5 |
|
mirna |
5 |
|
omicron |
5 |
|
age |
4 |
|
hnrnp c |
4 |
|
ifn |
4 |
|
immune breakthrough |
4 |
|
innate immune response |
4 |
|
re-infection |
4 |
|
rna binding protein |
4 |
|
vaccination |
4 |
|
interferon signaling |
3 |
|
stat1 |
3 |
|
mers (disease) - treatment |
2 |
